Menu
Back to Journals » Hepatic Medicine: Evidence and Research » Volume 2
Hepatic Medicine: Evidence and Research
ISSN: 1179-1535
- View all (176)
- Volume 15, 2023 (13)
- Volume 14, 2022 (13)
- Volume 13, 2021 (16)
- Volume 12, 2020 (16)
- Volume 11, 2019 (16)
- Volume 10, 2018 (13)
- Volume 9, 2017 (10)
- Volume 8, 2016 (15)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5, 2013 (7)
- Volume 4, 2012 (7)
- Volume 3, 2011 (14)
- Volume 2, 2010 (14)
- Volume 1, 2009 (2)
Archive: Volume 2, 2010
Update on new approaches in the management of hepatocellular carcinoma
Giuseppe Cabibbo, Michela Antonucci, Chiara Genco
Hepatic Medicine: Evidence and Research 2010, 2:163-172
Published Date: 26 November 2010
Relationship between serum HBsAg level, HBV DNA level, and peripheral immune cells in patients with chronic hepatitis B virus infection
RM Mukherjee, P Balkumar Reddy, Jyothi Arava, et al
Hepatic Medicine: Evidence and Research 2010, 2:157-162
Published Date: 16 November 2010
Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma
Jen-Jung Pan, Milind Javle, Mie Mie Thinn, et al
Hepatic Medicine: Evidence and Research 2010, 2:147-155
Published Date: 2 November 2010
Potential treatment options and future research to increase hepatitis C virus treatment response rate
Veronica TenCate, Bruno Sainz Jr, Scott J Cotler, et al
Hepatic Medicine: Evidence and Research 2010, 2:125-145
Published Date: 1 October 2010
Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine
Liang Wang
Hepatic Medicine: Evidence and Research 2010, 2:111-124
Published Date: 17 August 2010
A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection
Nan Xiao, Shuang Shi, Hui Zhuang
Hepatic Medicine: Evidence and Research 2010, 2:99-109
Published Date: 28 July 2010
Optimal management of hepatorenal syndrome in patients with cirrhosis
Paolo Angeli, Filippo Morando
Hepatic Medicine: Evidence and Research 2010, 2:87-98
Published Date: 21 June 2010
Anti-inflammatory action of insulin via induction of Gadd45-β transcription by the mTOR signaling pathway
Katherine D Bortoff, Adam B Keeton, J Lee Franklin, et al
Hepatic Medicine: Evidence and Research 2010, 2:79-85
Published Date: 24 June 2010
Mice with null mutation of Ceacam1 develop nonalcoholic steatohepatitis
Sumona Ghosh, Meenakshi Kaw, Payal R Patel, et al
Hepatic Medicine: Evidence and Research 2010, 2:69-78
Published Date: 31 May 2010
Liver stiffness: a novel parameter for the diagnosis of liver disease
Sebastian Mueller, Laurent Sandrin
Hepatic Medicine: Evidence and Research 2010, 2:49-67
Published Date: 25 May 2010
Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes
Katherine S Koch, Hyam L Leffert
Hepatic Medicine: Evidence and Research 2010, 2:39-47
Published Date: 23 March 2010
Mechanism of the inhibitory effect of ghrelin in sepsis
Asha Jacob, Rongqian Wu, Mian Zhou, et al
Hepatic Medicine: Evidence and Research 2010, 2:33-38
Published Date: 23 February 2010
Insulin-like growth factor binding protein-3 is required for the regulation of rat oval cell proliferation and differentiation in the 2AAF/PHX model
Nicole C Steiger-Luther, Houda Darwiche, Seh-Hoon Oh, et al
Hepatic Medicine: Evidence and Research 2010, 2:13-32
Published Date: 3 February 2010
Cyclic AMP-guanine exchange factor activation inhibits JNK-dependent lipopolysaccharide-induced apoptosis in rat hepatocytes
Kathleen Ponzetti, Melissa King, Anna Gates, et al
Hepatic Medicine: Evidence and Research 2010, 2:1-11
Published Date: 11 January 2010